切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2021, Vol. 07 ›› Issue (01) : 60 -63. doi: 10.3877/cma.j.issn.2095-9605.2021.01.012

所属专题: 文献

综述

脂质重分布在靶器官损害中的作用研究进展
刘孝琪1, 马坤岭1,()   
  1. 1. 210009 南京,东南大学附属中大医院肾内科,东南大学肾脏病研究所,东南大学医学院
  • 收稿日期:2020-06-04 出版日期:2021-02-28
  • 通信作者: 马坤岭
  • 基金资助:
    国家自然科学基金面上项目(81970629); 江苏省重点研发计划项目(BE2018744); 江苏省医学重点人才项目(ZDRCA2016077)

Advances in the role of lipid redistribution in target organ damage

Xiaoqi Liu1, Kunling Ma1()   

  • Received:2020-06-04 Published:2021-02-28
  • Corresponding author: Kunling Ma
引用本文:

刘孝琪, 马坤岭. 脂质重分布在靶器官损害中的作用研究进展[J]. 中华肥胖与代谢病电子杂志, 2021, 07(01): 60-63.

Xiaoqi Liu, Kunling Ma. Advances in the role of lipid redistribution in target organ damage[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2021, 07(01): 60-63.

[1]
Beckman M. Cell biology - Great balls of fat [J]. Science, 2006, 311(5765): 1232-1234.
[2]
Ali AT, Ferris WF, Naran NH, et al. Insulin Resistance in the Control of Body Fat Distribution: A New Hypothesis [J]. Hormone and Metabolic Research, 2011, 43(2): 77-80.
[3]
Rasouli N, Molavi B, Elbein SC, et al. Ectopic fat accumulation and metabolic syndrome [J]. Diabetes Obesity & Metabolism, 2007, 9(1): 1-10.
[4]
Van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity [J]. Physiology & Behavior, 2008, 94(2): 231-241.
[5]
Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis [J]. Nature Reviews Nephrology, 2009, 5(12): 713-721.
[6]
Stout MB, Justice JN, Nicklas BJ, et al. Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty [J]. Physiology (Bethesda), 2017, 32(1): 9-19.
[7]
Paruthiyil S, Hagiwara SI, Kundassery K, et al. Sexually dimorphic metabolic responses mediated by CRF2 receptor during nutritional stress in mice [J]. Biology of Sex Differences, 2018.
[8]
Wang Y, Ji X, Dai S, et al. Cadmium induced redistribution of cholesterol by upregulating ABCA1 and downregulating OSBP [J]. Journal of Inorganic Biochemistry, 2018, 189: 199-207.
[9]
Piche ME, Vasan SK, Hodson L, et al. Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk [J]. Current Opinion in Lipidology, 2018, 29(4): 285-92.
[10]
Verhaegen AA, Van Gaal LF. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options [J]. Journal of Endocrinological Investigation, 2017, 40(11): 1165-1174.
[11]
Bowles NP, Karatsoreos IN, Li X, et al. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome[J]. Proc Natl Acad Sci USA, 2015, 112(1): 285-290.
[12]
Nohturfft A, Debose-boyd RA, Scheek S, et al. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi [J]. Proceedings of the National Academy of Sciences of the United States of America, 1999, 96(20): 11235-11240.
[13]
Zhang Y, Ma KL, Ruan XZ, et al. Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury [J]. International Journal of Biological Sciences, 2016, 12(5): 569-579.
[14]
Ruan XZ, Moorhead JF, Varghese Z. Lipid redistribution in renal dysfunction [J]. Kidney International, 2008, 74(4): 407-409.
[15]
Zamboni M, Armellini F, Harris T, et al. Effects of age on body fat distribution and cardiovascular risk factors in women [J]. American Journal of Clinical Nutrition, 1997, 66(1): 111-115.
[16]
Denino W F, Tchernof A, Dionne I J, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women [J]. Diabetes Care, 2001, 24(5): 925-932.
[17]
Hughes VA, Roubenoff R, Wood M, et al. Anthropometric assessment of 10-y changes in body composition in the elderly [J]. American Journal of Clinical Nutrition, 2004, 80(2): 475-482.
[18]
Araki S, Okazaki M, Goto S. Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids [J]. Gerontology, 2004, 50(4): 206-215.
[19]
Bays HE, Gonzalez-campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity [J]. Expert review of cardiovascular therapy, 2008, 6(3): 343-368.
[20]
Tchkonia T, Corkey BE, Kirkland JL. Current Views of the Fat Cell as an Endocrine Cell: Lipotoxicity [M]. 2006.
[21]
Cartwright MJ, Tchkonia T, Kirkland JL. Aging in adipocytes: Potential impact of inherent, depot-specific mechanisms [J]. Experimental Gerontology, 2007, 42(6): 463-471.
[22]
Kirkland JL, Hollenberg CH, Gillon WS. Age, anatomic site, and the replication and differentiation of adipocyte precursors[J]. Am J Physiol, 1990, 258(2 Pt 1): 206-210.
[23]
Karagiannides I, TchkoniaT, Dobson DE, et al. Altered expression of C/EBP family members results in decreased adipogenesis with aging[J]. American Journal of Physiology Regulatory Integrative & Comparative Physiology, 2001, 280(6): R1772.
[24]
Tchkonia T, Lenburg M, Thomou T, et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns[J]. Am J Physiol Endocrinol Metab, 2007, 292(1): E298.
[25]
Gesta S, M Blüher, Yamamoto Y, et al. Gesta, S. et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution[J]. Proceedings of the National Academy of Sciences, 2006, 103(17): 6676-6681.
[26]
Harmelen VV, Röhrig K, Hauner HJMC, et al. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects [J]. Metabolism-clinical & Experimental,2004, 53(5): 632-637.
[27]
Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health [J]. International Journal of Obesity, 2010, 34(6): 949-959.
[28]
Tchernof A, Despres J P . Pathophysiology of Human Visceral Obesity: An Update[J]. Physiological Reviews, 2013, 93(1): 359-404.
[29]
Kramer FM, Stunkard AJ, Marshall KA, et al. Breast-feeding reduces maternal lower-body fat [J]. Journal of the American Dietetic Association, 1993, 93(4): 429-433.
[30]
Shimokata H, Tobin JD, Muller DC, et al. Studies in the distribution of body-fat .1. effects of age, sex, and obesity [J]. Journals of Gerontology, 1989, 44(2): M66-M75.
[31]
Lemieux S, Prudhomme D, Bouchard C, et al. Sex-differences in the relation of visceral adipose-tissue accumulation to total-body fatness [J]. American Journal of Clinical Nutrition, 1993, 58(4): 463-467.
[32]
Elbers JMH, Asscheman H, Seidell JC, et al. Long-term testosterone administration increases visceral fat in female to male transsexuals [J]. Journal of Clinical Endocrinology & Metabolism, 1997, 82(7): 2044-2047.
[33]
Elbers JMH, Asscheman H, Seidell JC, et al. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals [J]. American journal of physiology Endocrinology and metabolism, 1999, 276(2): E317-E325.
[34]
Elbers JMH, Giltay EJ, Teerlink T, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects [J]. Clinical Endocrinology, 2003, 58(5): 562-571.
[35]
Pablo DJ, Prutsky G, Leppin A, et al. Drugs commonly associated with weight change: a systematic review and meta-analysis [J]. Journal of Clinical Endocrinology & Metabolism, 2015, 100(2): 363-370.
[36]
Wilding J. Thiazolidinediones, insulin resistance and obesity: finding a balance [J]. International Journal of Clinical Practice, 2006, 60(10): 1272-1280.
[37]
Clement k, Vaisse C, Mmanning BS, et al. Genetic-variation in the beta(3)-adrenergic receptor and an increased capacity to gain weight in patients with morbid-obesity [J]. New England Journal of Medicine, 1995, 333(6): 352-354.
[38]
Belcastro V, D'egidio C, Striano P, et al. Metabolic and endocrine effects of valproic acid chronic treatment [J]. Epilepsy Research, 2013, 107(1-2): 1-8.
[39]
Menard C, Pfau ML, Hodes GE, et al. Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience [J]. Neuropsychopharmacology, 2017, 42(1): 62-80.
[40]
Ruan XZ, Varghese Z, Moorhead J F. An update on the lipid nephrotoxicity hypothesis [J]. Nat Rev Nephrol, 2009, 5(12): 713-721.
[41]
Fabbrini E, Mohammed BS, Magkos F, et al. Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease [J]. 2008, 134(2): 424-431.
[42]
Canoy D, Boekholdt SM, Wareham N, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort:a population-based prospective study [J]. 2006, 691(13): 3043-3052.
[43]
Frayn K. Adipose tissue as a buffer for daily lipid flux[J]. Diabetologia, 2002, 45(9): 1201-1210.
[44]
Vasan SK. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk[J]. International journal of obesity, 2018, 42(4): 850-857.
No related articles found!
阅读次数
全文


摘要